During the past decade, Genetesis Facility conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Genetesis Facility" are "Acute Myocardial Injuries" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Myocardial Infarction" (1 trials), "Cardiac Disease" (1 trials) and "Coronary Microvascular Dysfunction" (1 trials). Many other conditions were trialed in "Genetesis Facility" in a lesser frequency.

Most popular intervention types in "Genetesis Facility" are "Device" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "CardioFlux" (5 trials) and "CardioFlux Magnetocardiography" (1 trials). Other intervention names were less common.

The vast majority of trials in "Genetesis Facility" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Genetesis Facility". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Genetesis Facility, 3 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Genetesis Facility, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".